Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-06-28
DOI
10.3389/fnagi.2017.00210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid Deposition in Early Onset versus Late Onset Alzheimer's Disease
- (2018) Hanna Cho et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
- (2017) Ina S. Almdahl et al. Frontiers in Aging Neuroscience
- Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease
- (2017) Sarah Jesse et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Markers for Alzheimer's Disease over the Lifespan: Effects of Age and the APOEε4 Genotype
- (2017) Julius Popp et al. JOURNAL OF ALZHEIMERS DISEASE
- C-Terminal Threonine Reduces Aβ 43 Amyloidogenicity Compared with Aβ 42
- (2016) Saketh Chemuru et al. JOURNAL OF MOLECULAR BIOLOGY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study
- (2016) Camilla Lauridsen et al. Frontiers in Aging Neuroscience
- Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
- (2015) N. Le Bastard et al. CLINICAL CHEMISTRY
- The Role of PGRN in Alzheimer’s Disease
- (2015) Hua Jing et al. MOLECULAR NEUROBIOLOGY
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
- (2015) Malin Wennström et al. PLoS One
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
- (2015) Mattias Vågberg et al. PLoS One
- The C-Terminal Threonine of Aβ43 Nucleates Toxic Aggregation via Structural and Dynamical Changes in Monomers and Protofibrils
- (2014) Alexander E. Conicella et al. BIOCHEMISTRY
- Aβ43 Is the Earliest-Depositing Aβ Species in APP Transgenic Mouse Brain and Is Converted to Aβ41 by Two Active Domains of ACE
- (2013) Kun Zou et al. AMERICAN JOURNAL OF PATHOLOGY
- The Diagnostic Value of CSF Amyloid-β43 in Differentiation of Dementia Syndromes
- (2013) Kim Bruggink et al. Current Alzheimer Research
- The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
- (2013) Anna Sandebring et al. PLoS One
- Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement
- (2012) R. Ossenkoppele et al. BRAIN
- Does Alzheimers Disease with Early Onset Progress Faster than with Late Onset A Case-Control Study of Clinical Progression and Cerebrospinal Fluid Biomarkers
- (2012) H. Grønning et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Potent amyloidogenicity and pathogenicity of Aβ43
- (2011) Takashi Saito et al. NATURE NEUROSCIENCE
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden
- (2010) Gil D. Rabinovici et al. BRAIN
- The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions
- (2010) Lina Keller et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains
- (2009) Hedvig Welander et al. JOURNAL OF NEUROCHEMISTRY
- Age, Neuropathology, and Dementia
- (2009) George M. Savva et al. NEW ENGLAND JOURNAL OF MEDICINE
- CSF biomarker levels in early and late onset Alzheimer's disease
- (2008) Femke H. Bouwman et al. NEUROBIOLOGY OF AGING
- The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease
- (2007) Lidia Glodzik-Sobanska et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started